804 related articles for article (PubMed ID: 7519102)
1. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
[TBL] [Abstract][Full Text] [Related]
3. Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood.
Stevens MC; Maude GH; Beckford M; Grandison Y; Mason K; Taylor B; Serjeant BE; Higgs DR; Teal H; Weatherall DJ
Blood; 1986 Feb; 67(2):411-4. PubMed ID: 2417644
[TBL] [Abstract][Full Text] [Related]
4. The red cell distribution width in sickle cell disease--is it of clinical value?
Thame M; Grandison Y; Mason K; Thompson M; Higgs D; Morris J; Serjeant B; Serjeant G
Clin Lab Haematol; 1991; 13(3):229-37. PubMed ID: 1794225
[TBL] [Abstract][Full Text] [Related]
5. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
[TBL] [Abstract][Full Text] [Related]
6. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
7. Volume regulation and KCl cotransport in reticulocyte populations of sickle and normal red blood cells.
Quarmyne MO; Risinger M; Linkugel A; Frazier A; Joiner C
Blood Cells Mol Dis; 2011 Aug; 47(2):95-9. PubMed ID: 21576026
[TBL] [Abstract][Full Text] [Related]
8. The development of haematological changes in homozygous sickle cell disease: a cohort study from birth to 6 years.
Serjeant GR; Grandison Y; Lowrie Y; Mason K; Phillips J; Serjeant BE; Vaidya S
Br J Haematol; 1981 Aug; 48(4):533-43. PubMed ID: 7272216
[TBL] [Abstract][Full Text] [Related]
9. Developmental pattern of splenic dysfunction in sickle cell disorders.
Pearson HA; Gallagher D; Chilcote R; Sullivan E; Wilimas J; Espeland M; Ritchey AK
Pediatrics; 1985 Sep; 76(3):392-7. PubMed ID: 2412200
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anemia, red blood cell morphology, and reticulocyte count for sickle cell disease.
Losek JD; Hellmich TR; Hoffman GM
Ann Emerg Med; 1992 Aug; 21(8):915-8. PubMed ID: 1497156
[TBL] [Abstract][Full Text] [Related]
11. [Blood count abnormalities in the association of sickle cell disease and malaria in clinical hematology at the CNHU-HKM in Cotonou (Bénin)].
Zohoun AGC; Bagloagbodande T; Adanho A; Massi R; Houssou B; Orou Guiwa GG; Dèhoumon J; Mehou J; Anani L; Vovor A; Kindegazard D
Med Trop Sante Int; 2024 Mar; 4(1):. PubMed ID: 38846115
[TBL] [Abstract][Full Text] [Related]
12. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
13. Microcytosis associated with sickle cell anemia.
Glader BE; Propper RD; Buchanan GR
Am J Clin Pathol; 1979 Jul; 72(1):63-4. PubMed ID: 453112
[TBL] [Abstract][Full Text] [Related]
14. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.
Ware RE; Eggleston B; Redding-Lallinger R; Wang WC; Smith-Whitley K; Daeschner C; Gee B; Styles LA; Helms RW; Kinney TR; Ohene-Frempong K
Blood; 2002 Jan; 99(1):10-4. PubMed ID: 11756146
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell distribution width index in some hematologic diseases.
Roberts GT; El Badawi SB
Am J Clin Pathol; 1985 Feb; 83(2):222-6. PubMed ID: 3969961
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
17. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
Embury SH; Clark MR; Monroy G; Mohandas N
J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia.
Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C
Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638
[TBL] [Abstract][Full Text] [Related]
19. Haematological change in sickle cell-haemoglobin C disease and in sickle cell-beta thalassaemia: a cohort study from birth.
Stevens MC; Maude GH; Beckford M; Grandison Y; Mason K; Serjeant BE; Taylor B; Topley JM; Serjeant GR
Br J Haematol; 1985 Jun; 60(2):279-92. PubMed ID: 4005180
[TBL] [Abstract][Full Text] [Related]
20. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.
Aleluia MM; da Guarda CC; Santiago RP; Fonseca TC; Neves FI; de Souza RQ; Farias LA; Pimenta FA; Fiuza LM; Pitanga TN; Ferreira JR; Adorno EV; Cerqueira BA; Gonçalves MS
Lipids Health Dis; 2017 Apr; 16(1):74. PubMed ID: 28399852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
